Delayed release anti-fungal product, use and formulation thereof

An anti-fungal product comprising:

• a first anti-fungal dosage form, a second anti-fungal dosage form, and a third anti-fungal dosage form, each of said first, second and third anti-fungal dosage forms comprising an anti-fungal and a pharmaceutically acceptable carrier, said three dosage forms having different release profiles, said anti-fungal product reaching a Cmax in less than about twelve hours after initial release of anti-fungal from the product, said first, second and third dosage forms, each being a delayed release dosage form, wherein the anti-fungal released from the first dosage form reaches a Cmax in serum in from 0.5 to 2 hours after initial release of anti-fungal from the product, wherein the anti-fungal released from the second dosage form reaches a Cmax in serum in no more than about 4 hours after initial release of anti-fungal from the product and after Cmax is reached for anti-fungal from the first dosage form and the anti-fungal released from the third dosage form reaches a Cmax in serum after the Cmax is reached for the anti-fungal released from the second dosage form.